Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Amelia Vernochet"'
Autor:
Florence Herr, Manon Dekeyser, Jerome Le Pavec, Christophe Desterke, Andrada-Silvana Chiron, Karen Bargiel, Olaf Mercier, Amelia Vernochet, Elie Fadel, Antoine Durrbach
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1299 (2023)
Calcineurin inhibitors have improved graft survival in solid-organ transplantation but their use is limited by toxicity, requiring a switch to another immunosuppressor in some cases. Belatacept is one option that has been shown to improve graft and p
Externí odkaz:
https://doaj.org/article/c7cba020b1064bcab771e8197fd3e721
Autor:
Xiaomeng Zhang, Florence Herr, Amelia Vernochet, Hans K. Lorenzo, Séverine Beaudreuil, Antoine Dürrbach
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Introduction: Focal and segmental glomerulosclerosis (FSGS) is a frequent form of glomerulonephritis that may be caused by a soluble permeability factor and regulated by the immune system. We previously described a soluble form of calcium/calmodulin-
Externí odkaz:
https://doaj.org/article/f7a4703d71944e999b0b425b0cab34c8
Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation.
Autor:
Massimo Giuliani, Maud Fleury, Amelia Vernochet, Farah Ketroussi, Denis Clay, Bruno Azzarone, Jean Jacques Lataillade, Antoine Durrbach
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19988 (2011)
Human bone marrow mesenchymal stem cells (BM-MSC) are multipotent progenitor cells that have transient immunomodulatory properties on Natural Killer (NK) cells, Dendritic Cells (DC), and T cells. This study compared the use of MSC isolated from bone
Externí odkaz:
https://doaj.org/article/521519455890454288e78fa223c128dc
Autor:
Karen Bargiel, Florence Herr, Bernard Vanhove, Christophe Desterke, Manon Dekeyser, Antoine Durrbach, Fan Ye, Radu Vadanici, Amelia Vernochet
Publikováno v:
American Journal of Transplantation. 22:489-503
Belatacept was developed to replace calcineurin inhibitors in kidney transplantation. Its use is associated with better kidney transplant function, a lower incidence of anti-donor antibodies and higher graft survival. However, it is also associated w
Publikováno v:
Stem cells and development. 28(1)
Mesenchymal stem cells (MSCs) are powerful immunomodulators that regulate the diverse functions of immune cells involved in allogeneic reactions, such as T cells and natural killer (NK) cells, through cell-cell contact or secreted factors. Exosomes s
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 199:515-523
RESUME En transplantation, les traitements immunosuppresseurs ont permis d’accroitre la survie des greffons et des malades. Cependant ces traitements sont associes a des risques toxiques et des complications infectieuses ou tumorales. Le mise en ev
Autor:
Monique Ortin-Serrano, Serge Romana, Amelia Vernochet, Catherine Guettier, Alexia Letierce, Antoine Durrbach, Sophie Ferlicot, Olivier Brégerie
Publikováno v:
Histopathology. 56:188-197
Ferlicot S, Vernochet A, Romana S, Ortin-Serrano M, Letierce A, Bregerie O, Durrbach A & Guettier C (2010) Histopathology56, 188–197 Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells Aims:
Autor:
Bruno Azzarone, Catherine Ledent, Myriam Saïd, Amelia Vernochet, Séverine Beaudreuil, Stanislas Grassin-Delyle, Christos Chatziantoniou, Aimé Vazquez, Hélène François, Sophie Vandermeersch, Antoine Durrbach, Ninoslav Ivanovski, Christophe Desterke, Meriem Dalia, Lola Lecru, Bernard Charpentier, Sophie Ferlicot, Aurore Devocelle, Julien Giron-Michel
Publikováno v:
Kidney international. 88(1)
Chronic kidney disease, secondary to renal fibrogenesis, is a burden on public health. There is a need to explore new therapeutic pathways to reduce renal fibrogenesis. To study this, we used unilateral ureteral obstruction (UUO) in mice as an experi
Autor:
Amelia Vernochet, Antoine Durrbach, Zaeem Noman, Massimo Giuliani, Noufissa Oudrhiri, Bruno Azzarone, Salem Chouaib, Annelise Bennaceur-Griscelli
Publikováno v:
Blood. 118(12)
A major issue in immunosuppressive biotherapy is the use of mesenchymal stem cells (MSCs) that harbor regulatory capacity. However, currently used bone marrow-derived MSCs (BM-MSCs) are short-lived and cannot assure long lasting immunoregulatory func
Autor:
Bruno Azzarone, Denis Clay, Maud Fleury, Farah Ketroussi, Amelia Vernochet, Massimo Giuliani, Jean Jacques Lataillade, Antoine Durrbach
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 5, p e19988 (2011)
PLoS ONE, Vol 6, Iss 5, p e19988 (2011)
Human bone marrow mesenchymal stem cells (BM-MSC) are multipotent progenitor cells that have transient immunomodulatory properties on Natural Killer (NK) cells, Dendritic Cells (DC), and T cells. This study compared the use of MSC isolated from bone